Literature DB >> 9555123

Studies on the antibodies to human herpesvirus type 6 among Hungarian patients with asymptomatic HIV infection.

C L Maródi1, A Csiszár, B Sierra-Vazquez, D Di Luca, E Barabás, K Nagy, J Ongrádi.   

Abstract

The occurrence and the possible role in promoting HIV infection by human herpesvirus type 6 (HHV-6) have not yet been revealed in Hungary. In different groups of patients, serum titre of IgM and IgG antibodies, as well as avidity of IgG were quantitated by indirect immunofluorescence and an enzyme-linked immunosorbent assay, using isolate U1102 of HHV-6 variant A as antigen. In 60% of HIV-seronegative adult controls, high avidity IgG antibodies were found in low titre suggesting childhood infection. In HIV-seronegative persons with high risk behaviour for HIV-infection, both IgM and low avidity IgG were frequently found in higher titre, representing either primary or frequent reinfections, or reactivation of latent HHV-6. In asymptomatic HIV-seropositive patients, high titre of high avidity IgG antibodies was predominant, proving virus infection in the near past. These results indicate the contribution of HHV-6 to immunosuppression prior to AIDS, predisposing the organism to HIV infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9555123     DOI: 10.1007/BF02904698

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  33 in total

Review 1.  Three new human herpesviruses (HHV6, 7, and 8).

Authors:  J A Levy
Journal:  Lancet       Date:  1997-02-22       Impact factor: 79.321

2.  HBLV (or HHV-6) in human cell lines.

Authors:  D V Ablashi; S Z Salahuddin; S F Josephs; F Imam; P Lusso; R C Gallo; C Hung; J Lemp; P D Markham
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

3.  Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections.

Authors:  R F Pass; P D Griffiths; A M August
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

4.  Effect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers.

Authors:  A Linde; E Fridell; H Dahl; J Andersson; P Biberfeld; B Wahren
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

5.  Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6.

Authors:  P Lusso; A De Maria; M Malnati; F Lori; S E DeRocco; M Baseler; R C Gallo
Journal:  Nature       Date:  1991-02-07       Impact factor: 49.962

6.  Antigenic relationships among human herpesvirus-6 isolates.

Authors:  B Chandran; S Tirawatnapong; B Pfeiffer; D V Ablashi
Journal:  J Med Virol       Date:  1992-08       Impact factor: 2.327

7.  Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome.

Authors:  D Di Luca; M Zorzenon; P Mirandola; R Colle; G A Botta; E Cassai
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

8.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

9.  Restriction endonuclease mapping and molecular cloning of the human herpesvirus 6 variant B strain Z29 genome.

Authors:  G J Lindquester; N Inoue; R D Allen; J W Castelli; F R Stamey; T R Dambaugh; J J O'Brian; R M Danovich; N Frenkel; P E Pellett
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Characterization of a new strain of HHV-6 (HHV-6SF) recovered from the saliva of an HIV-infected individual.

Authors:  J A Levy; F Ferro; E T Lennette; L Oshiro; L Poulin
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.